References
- Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women: Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999;29:745-758. https://doi.org/10.1086/520427
- Park KH, Oh WS, Kim ES, et al. Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department. Int J Infect Dis 2014;23:8-13. https://doi.org/10.1016/j.ijid.2013.12.021
- Kim K, Lee CC, Rhee JE, et al. The effects of an institutional care map on the admission rates and medical costs in women with acute pyelonephritis. Acad Emerg Med 2008;15:319-323. https://doi.org/10.1111/j.1553-2712.2008.00070.x
- Lee SS, Kim Y, Chung DR. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. J Infect 2011;62:159-164. https://doi.org/10.1016/j.jinf.2010.10.009
- Lee S, Song do Y, Cho SH, Kwon KT. Impact of extended-spectrum beta-lactamase on acute pyelonephritis treated with empirical ceftriaxone. Microb Drug Resist 2014;20:39-44. https://doi.org/10.1089/mdr.2013.0075